Clinical Trial Update: A Phase 1b Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus [Phase 1]

View source ↗

Summary

A Phase 1b study evaluating LAPS-Exendin in subjects with Type 2 diabetes mellitus; the document provides an update but does not disclose the current status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• LAPS-Exendin

Snippet

Sponsor: Hanmi Pharmaceutical Company Limited | Conditions: Diabetes Mellitus | Phase 1 | Status: UNKNOWN